Public Sector Pension Investment Board lifted its stake in shares of Teleflex Incorporated (NYSE:TFX – Free Report) by 48.6% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 286,801 shares of the medical technology company’s stock after purchasing an additional 93,799 shares during the quarter. Public Sector Pension Investment Board’s holdings in Teleflex were worth $35,701,000 as of its most recent SEC filing.
Several other large investors also recently modified their holdings of the stock. GAMMA Investing LLC raised its position in shares of Teleflex by 9.8% in the 3rd quarter. GAMMA Investing LLC now owns 921 shares of the medical technology company’s stock valued at $115,000 after buying an additional 82 shares in the last quarter. Hsbc Holdings PLC lifted its holdings in shares of Teleflex by 4.7% during the 1st quarter. Hsbc Holdings PLC now owns 1,861 shares of the medical technology company’s stock worth $222,000 after acquiring an additional 84 shares during the period. Hantz Financial Services Inc. boosted its position in shares of Teleflex by 30.5% during the 3rd quarter. Hantz Financial Services Inc. now owns 445 shares of the medical technology company’s stock worth $56,000 after acquiring an additional 104 shares in the last quarter. Baldwin Wealth Partners LLC MA boosted its position in shares of Teleflex by 7.5% during the 3rd quarter. Baldwin Wealth Partners LLC MA now owns 1,702 shares of the medical technology company’s stock worth $213,000 after acquiring an additional 119 shares in the last quarter. Finally, Allworth Financial LP boosted its position in shares of Teleflex by 91.8% during the 2nd quarter. Allworth Financial LP now owns 349 shares of the medical technology company’s stock worth $44,000 after acquiring an additional 167 shares in the last quarter. 95.62% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
A number of research analysts recently issued reports on TFX shares. Bank of America raised shares of Teleflex from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $145.00 to $158.00 in a research note on Monday, September 28th. Royal Bank Of Canada upped their target price on Teleflex from $155.00 to $175.00 and gave the stock an “outperform” rating in a research note on Friday, November 6th. Wells Fargo & Company upped their target price on Teleflex from $138.00 to $167.00 and gave the stock an “equal weight” rating in a research note on Friday, November 6th. Zacks Research downgraded Teleflex from a “strong-buy” rating to a “hold” rating in a report on Friday, October 23rd. Finally, Truist Financial lifted their price target on Teleflex from $142.00 to $167.00 and gave the company a “hold” rating in a research note on Monday, November 9th. One equities research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat.com, Teleflex currently has an average rating of “Moderate Buy” and a consensus target price of $163.30.
Get Our Latest Research Report on Teleflex
Teleflex Stock Up 4.1%
Shares of NYSE TFX opened at $166.09 on Thursday. The company has a current ratio of 2.01, a quick ratio of 1.59 and a debt-to-equity ratio of 0.44. The company has a market cap of $6.59 billion, a price-to-earnings ratio of 20.18, a PEG ratio of 1.07 and a beta of 0.85. Teleflex Incorporated has a 12 month low of $100.18 and a 12 month high of $166.75. The stock has a 50-day moving average price of $135.04 and a two-hundred day moving average price of $128.21.
Teleflex (NYSE:TFX – Get Free Report) last posted its earnings results on Thursday, November 5th. The medical technology company reported $2.63 EPS for the quarter, topping analysts’ consensus estimates of $1.90 by $0.73. Teleflex had a net margin of 13.51% and a return on equity of 10.57%. The firm had revenue of $567.80 million during the quarter, compared to analysts’ expectations of $565.52 million. During the same quarter in the prior year, the business earned $3.67 earnings per share. The business’s revenue for the quarter was up .1% compared to the same quarter last year. As a group, analysts forecast that Teleflex Incorporated will post 7.67 earnings per share for the current fiscal year.
Teleflex Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 31st. Investors of record on Monday, November 16th will be given a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date is Monday, November 16th. Teleflex’s dividend payout ratio is currently 16.52%.
Teleflex Profile
Teleflex is a global medical technology company that develops, manufactures and markets single-use medical devices used by healthcare professionals in hospitals and other care settings. Its products support a range of procedures, including vascular access, anesthesia, critical care, surgery, urology and emergency medicine. The company’s offerings include vascular and interventional access devices, catheters, airway management products, surgical instruments and other devices used in diagnostic and therapeutic procedures.
Featured Stories
- Five stocks we like better than Teleflex
- Amazon’s Zoox Just Joined Uber—Could That Change the Robotaxi Threat?
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX – Free Report).
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.
